The difference is that GLP-1 users eat less because the drugs suppress their appetites, so the foods they do eat need to be packed with nutrients, Christen said
These results indicate that Semaglutide GLP-1 users lost significantly more weight compared to those using a placebo
Improved Metabolic Health: It has been shown to improve insulin sensitivity, reduce blood sugar levels, and lower HbA1c, making it beneficial for individuals with type 2 diabetes or prediabetes
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials FDA warns about unapproved GLP-1 drugs online, calls for accessible trials The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows
Many individuals with diabetes, high blood pressure, or other medical conditions can safely participate with proper oversight